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INTRODUCTION
Impaired carbohydrate tolerance is a common accompaniment of diabetic
ketoacidosis (1) and chronic renal failure (2).
is the presence of metabolic acidosis.

Common to both these states

Although several previous animal

(3-5) and in vitro (6-8) studies have suggested that acidosis per se may
result in an impairment of glucose metabolism, such an effect has not been
well studied in man and the mechanism(s) by which acidosis impairs glucose
metabolism have not been defined.
Haldane et.al. (9) were the first to examine the effect of metabolic
acidosis on glucose metabolism in man.

Following the injestion of ammonium

chloride they found an impairment of glucose tolerance which persisted for
some time following the return of blood pH to normal.

Walker et.al. (6)

noted decreased sensitivity to exogenously administered insulin in six
diabetics with ketoacidosis (blood pH <7.20) and improvement in insulin
sensitivity following correction of the acidosis.

However, these authors

could not exclude other changes in the diabetic state as responsible for the
improvement in insulin sensitivity.

In the only other study in man, Baird

(10) was unable to demonstrate any adverse effect of ammonium chloride induced
acidosis on the intravenous glucose tolerance test.

However, all of his

subjects were treated with quinalbarbitone prior to study and this could have
obscured any differences between the control and ammonium chloride treated
groups.
Mackler et.al. examined the effect of ammonium chloride induced metabolic
acidosis (mean blood pH and serum bicarbonate concentration = 7.06 and 6 mEq/L)
in dogs (3-5).

They found a consistent increase in fasting glucose concentra¬

tion, a blunted response to exogenous insulin, and impairment in the intra¬
venous glucose tolerance test.

They also observed a failure of the normal

decline in serum potassium and phosphate concentration (11-14) in response
to both insulin and glucose, again suggesting impaired sensitivity to the
action of insulin.

However, the interpretation of the above studies is

obscured by the fact that the dogs were also fasted over the three days
during which the metabolic acidosis was induced.

Thus, it is difficult to

differentiate an effect of acidosis versus fasting on the decline in glucose
tolerance.

In the only other study performed in dogs, Deuel and Gulick were

unable to demonstrate an effect of ammonium chloride-induced acidosis on
carbohydrate tolerance (15). In vitro studies employed the rat epididymal fat
pad (6), the rat hemidiaphragm (6,8), and circulating erythrocytes and
leukocytes (5,7) have also suggested that acidosis inhibitsglucose uptake
and oxidation.
To examine the effect of metabolic acidosis on glucose metabolism and
to define the relative contributions of impaired insulin resistance,
imparied beta-cell secretion of insulin, and augmented hepatic qlucose oroduction
to the carbohydrate intolerance, we studied 12 subjects with the glucose
clamp technique before and after the induction of chronic metabolic with
ammonium chloride.

METHODS
A.

Subjects:

(Table I).

from 22 to 31 were studied.

Twelve healthy volunteers ranging in age

They were evenly divided between males and

females and all were within 20% of their ideal body weight.

The middle

of the weight range for subjects of medium frame from the 1959 Metropolitan
Life Insurance Company table for desirable weight was used to determine ideal
body weiqht. All subjects were consuming a weight maintainina diet containing at
least 200 gms of carbohydrate per day for 3 days prior to study. Other than subjec

M.K., M.D. and M.S., who were on oral contraceptives, subjects consumed
no other medications for at least two weeks prior to study.
no family history of diabetes.
the 12 subjects.

There was

A total of 24 studies were performed on

All subjects were studied at 8 a.m. following a twelve

hour overnight fast.

Following the initial study each subject received

ammonium chloride in a dose of either 0.1 or 0.15 gm/kg of body weight
per day for three days and the study was repeated on the morning of the
fourth day.

Each subject thereby served as his own control.

The ammonium

chloride was administered in divided doses every 6 hours with the last dose
being given at 11 p.m. on the evening prior to study.

Although two subjects

complained of mild abnormal discomfort, there was no vomiting and all
continued on the diet as stated above.
Prior to each study a polyethylene catheter was inserted into an
anticubital vein under local xylocaine anesthesia for administration of all
test substances.
sampling.

A second catheter was inserted into a hand vein for blood

The hand was then inserted into a heated chamber in which the

air temperature was maintained at 70±2 degrees centigrade.

This was done

to insure arteriolization of venous blood (16).
B.

Hyperglycemic Clamp:

After a control period of at least thirty

minutes a priming infusion of glucose designed to rapidly raise the blood
glucose concentration to 125 gm/dl above the fasting level was administered
in a logarithmically falling manner over 15 minutes.

Arteriolized venous

blood was sampled every two minutes for the first ten minutes to quantitate
the early releasable insulin peak.
every five minutes for 110 minutes.

Thereafter, blood samples were drawn
The plasma glucose concentration was

rapidly determined (analytical delay was less than two minutes) on each sample
and the infusion rate of a 20% glucose solution was adjusted to maintain the blood

glucose concentration constant at 125 mg/dl above the basal level.

The

formula for the servo-correction is based upon the negative feedback
principle.

Thus, if the actual plasma glucose concentration is greater

than the goal, the glucose infusion rate is decreased and vice-versa.

Of

pertinence to this paper is the fact that the actual plasma glucose
concentration was maintained within narrow limits of the specified goal
(see Results).

Under these steady-state conditions of constant hyperglycemia

the amount of glucose infused (mg/kg of body weight/min) minus urinary losses
(mg/kg of body weight/min) is a measure of the glucose metabolized, M.
Although the clamp method does essentially eliminate variance from subject
to subject in blood glucose concentration, the plasma insulin levels are not
the same in all subjects.

In the euglycemic clamp (see below), insulin

levels vary only as a function of its metabolic clearance rate (MCR).

In

the hyperglycemic clamp insulin levels vary not only as a function of MCR,
but also on a function of the sensitivity of the beta cell to hyperglycemia.
The fact that insulin levels vary makes it essential to correct the value
for M in some manner to take this variance into account.

The simplest

technique is to compute the ratio of M to the plasma insulin level, I, that
is, to compute M/I.

The underlying mathematical assumptions of such a

computation are that M is linearly related to I and that there is no intercept
of M on I.

If either of these two assumptions is incorrect, then a more

complex formulation would be required.
might be justified.

For example, computation of an M/log I

We have chosen to correct for the insulin concentration

by the simplest possible technique, M/I.

The mean insulin concentration in

the 24 euglycemic and hyperglycemic clamp studies is 104 uU/ml (Tables 2 and 3)
with a standard deviation of ±32.

Within these reasonably narrow limits it

is doubtful whether more complex formulations would significantly change the
conclusions presented.

C.

Euglycemic Clamp:

A prime plus continuous infusion of crystalline

porcine insulin (Eli Lilly Co., Indianapolis, In.) was administered to obtain
constant hyperinsulinemia (17).

The primary dose was administered in a

logarithmically falling manner over ten minutes at which time the continuous
insulin infusion was begun.

The total amount of insulin infused during the

priming period was twice that infused during subsequent ten minute intervals.
The continuous infusion (40 mU/m
110 minutes.

p

surface area per min) was maintained for

In order to prevent insulin adsorption to glassware and to

the plastic infusion apparatus, infusates were prepared with the addition of
2 ml of the subject's whole blood per 50 ml of infusate.

Hypoglycemia with

its attendant counter-regulatory responses was prevented by the glucose clamp
technique (see under hyperglycemic clamp) which was used to maintain each
subject at his own basal blood glucose concentration during insulin
administration.

The initial glucose infusion rate was 2.0 mg/kg body weight/

min and was started four minutes after the insulin infusion was begun.

At

ten minutes the glucose infusion was increased to 3.0 mg/kg/min; these doses
were empirically determined.
minutes.

The first servo-correction was made at 14

Under the condition of constant euglycemia all of the glucose

infused (M) is metabolized and is thus a measure of the body's sensitivity
to insulin.

During the euglycemic clamp the effect of insulin on hepatic

glucose production was examined with tritiated glucose labeled in the 3
position ([%]glucose).

For 3 hours prior to beginning the insulin infusion,

each subject's glucose pool was labeled by a primed continuous infusion of
[^T] glucose.

The labeled glucose was administered as an initial intravenous

priming dose followed immediately by a continuous intravenous infusion at a
rate of about 0.25 uCi/min.

Plasma samples for determination of glucose

specific activity were taken at 30 minute intervals for the first two hours
and at 15 minute intervals for the subsequent hour.

A steady state plateau

glucose specific acticity was achieved in all subjects during the third
hour of [3t] glucose infusion and this plateau value was used to calculate
basal hepatic glucose production.

After 3 hours of continuous [^T] glucose

infusion, the euglycemic clamp was begun as previously described and the
continuous infusion of [~T] glucose was continued at the same rate.

During

the clamp study plasma samples for glucose specific activity were drawn
every 15 minutes.

Three control samples for amino acids and glucagon were

obtained prior to beginning both the euglycemic and heperglycemic clamp
studies; subsequent samples were drawn at 15-30 minute intervals.
D.

Calculations:

Hyperglycemic Clamp:

The fasting plasma insulin

concentration, the early (0-10 minute), late (20-120 min), and total plasma
insulin (I) responses, the amount of glucose metabolized (20-120 minute time
period) and the M/I ratio (a measure of tissue sensitivity to insulin) were
compared before and after NH^l loading.

The basal glucagon and amino acid

levels as well as the change in plasma glucagon and amino acid concentrations
following glucose were also compared before and after NH4C1 loading.
Euglycemic Clamp:

Tissue sensitivity to insulin (M/I ratio during time

= 20-120 minutes) and the metabolic clearance rate (MCR) of insulin were
compared before and after ammonium chloride loading.

The MCR of insulin was

calculated by dividing the insulin infusion rate by the steady state plasma
insulin concentration during the 40-120 minute time period minus the basal
insulin concentration.

Plasma glucagon and amino acid concentrations were

analyzed as described above for the hyperglycemic clamp.

Basal hepatic

glucose production before and after ammonium chloride loading was determined
3
by dividing the [ T] glucose infusion rate (counts/min) by the steady state
plateau of [ T] glucose specific activity during the last hour of the control
period.

Following insulin-glucose administration (euglycemic clamp) a non¬

steady state condition in glucose specific activity exists and hepatic glucose

production was approximately using the Steele equations (equations 4A and
5A, reference #18) average values for the rates of glucose turnover for the
intervals between two conservative sampling times.
All data are presented as the mean - SEM.

Statistical significance

between the difference of two means was calculated by paired T-test analysis.
E.

Analytical Procedures:

Plasma glucose analyses were performed

in duplicate on arterized venous samples using the glucose oxidase method
(Glucostat, Beckman Instruments Corp., Fullerton, Ca. 92634).

Insulin was

determined by radioimmunoassay with talc to separate bound from free insulin
(19).

Plasma glucagon was analyzed by radioimmunoassay with Unger antibody

30K (20).

For determination of amino acids, plasma proteins were removed by

precipitation with sulfosalicylic acid (21).

Amino acids were then determined

by automated ion exchange chromatography (22) with a Beckman 120C amino acid
analyzer (Beckman Instruments, Inc., Spinco Div., Palo Alto, Ca.) modified
for single column analysis of basic as well as acidic and neutral amino acids
(23).
For determination of [^T] glucose specific activity, plasma samples were
centrifuged immediately and plasma deproteinized using ZnS04 and Ba (0H)2 (24).
The filtrates were analyzed for glucose content by the glucose oxidase method
as previously described.

Aliquots (0.5 ml) of plasma filtrates were then

evaporated to dryness in counting vials in a partial vacuum at 70°C to eliminate
metabolic T2O.

The dried residues were redissolved in one ml of water, to

which 10 ml of aquasol was added for counting (Packard Model 3003 Tri-Carb
Liquid Scintillation Spectrometer, 78% efficiency, with internal quenching).

RESULTS
Hyperglycemic clamp:

Prior to NH^Cl the fasting blood glucose

concentration averaged 94-3 mg/dl.

Durino the period of sustained

hyperglycemia the mean glucose concentration of the five subjects
was 215-4 ma/dl.

Following NH^Cl the fastina blood glucose and

steady state hyperglycemic levels averaged 92-1 mq/dl and 218-1 mg/dl
respectively.

The stability of the blood glucose concentration during the

period of hyperglycemia is shown by the coefficient of variation which
averaged 3.9-0.61 during the control studies and 3.6-0.7% post NH4CI.
The amount of glucose metabolized (M) during the hyperalvcemic
clamp decreased from 9.09 ma/kg body wt./min. to 7.43 mg/Kq body wt./min.
followina NH4CI (p<0.10. Table 2).

The fasting plasma insulin

concentration in the 12 subjects following NH4CI (17-1 yU/ml) was
significantly hiqher than during the control study (13

-

1 yU/ml, p 0.02).

Following the creation of a square wave plateau of hyperglycemia, the
plasma insulin response was biphasic with an early burst of insulin
within the first six minutes followed by a gradually increasing phase of
insulin release that lasted until the end of the study.

There was no

difference in the early insulin response (0-10 min.) between the control
and NH4C1 studies (Table 2, Figure 1).

However, the late insulin response

(10-120 min.) tended to be greater following the induction of metabolic
acidosis and the plasma insulin concentration was statistically significantly
higher during the 10-60 minute period.

Tissue sensitivity to insulin

(M/I ratio) post NH^Cl decreased in all five subjects by an average of
32-6% (Table II, p<0.02).
The fastina plasma alucaaon concentration in the twelve subjects
following NH4CI was significantly higher than during the control study

(110 ± 18 pa/ml versus 95 - 17 pg/ml, p<0.01).

Followinq the creation

of a steady state plateau of hyperglycemia, plasma olucagon concentration
was suppressed similarly in both the pre and post NH4CI studies (Figure 2).
Euglycemic Clamp (Table 3).
The prime-continuous insulin infusion resulted in a steady state
plasma insulin level (10-120 minutes) that averaoed 114 - 4 yli/ml during
the control study and

110-6

yll/ml following the induction of metabolic

acidosis with NH4CI (Fiqure 3).

The stability of the plasma insulin

concentration is shov/n by the coefficient of variation which averaoed
9-1% durina the control study and 10 - 1% followinq NF^Cl.

There was no

difference in the metabolic clearance rate of insulin (insulin infusion rate
divided by the increase above basal in the 40-120 minute insulin
concentration) between the control (415 - 23 ml/min./M2) and acidotic
(412 - 27 ml/min/M^) studies.
The fastina plasma glucose concentrations during the control and
NH4CI studies were 91-2 mg/dl and

88

- 1 mo/dl.

During the period of

hyperinsulinemia, the plasma alucose concentration was held constant
at the basal level with a mean coefficient of variation of 4.7

-

0.4%

and 4.2 - 0.3% respectively.
The amount of glucose metabolized following NH4CI decreased from
7.13 - 0.77 to 6.15 - 0.54 mo/kg body wt/min (p=0.07) and the M/I ratio
declined from 6.33 - 0.60 to 5.61 - 0.^5 in units of (mg/kq/min per yU/ml)
X 100 (p<0.10).
Followinq the infusion of insulin and olucose, plasma olucaoon
suppressed normally during the control study (p<0.01, figure 4).

Following the induction of metabolic acidosis with NH^Cl, the suppression
of glucagon by insulin and glucose was less complete, becoming statistically
significantly different at only the 105 and 120 minute values.

Plasma

amino acid concentrations were measured in subjects M.K., A.P., and M.S.
No difference in fasting levels were observed between the control and
NH4CI studies.

Following the creation of hyperinsulinemia, a decrease

in the levels of valine, leucine, isoleucine, phenylalanine, threonine,
tyrosine, methionine, and serine was observed.
DISCUSSION
Previous studies examining the effect of metabolic acidosis on
glucose metabolism have yielded conflicting results.

Several reports

have suggested that ammonium chloride-induced metabolic acidosis results
in an impairment of the intravenous glucose tolerance test and decreased
tissue sensitivity to exogenous insulin (3-6).

However, several

investigators have failed to find a decrease in glucose tolerance (10,15)
and the plasma insulin response to glucose following metabolic acidosis
has not been reported.
In the present study we employed the glucose clamp technique to
examine the relative contributions of impaired beta cell secretion of
insulin versus tissue insensitivity to insulin in the genesis of the glucose
intolerance following chronic ammonium chloride induced metabolic acidosis.
This technique offers several advantages over the usual techniques employed to
assess glucose metabolism:
(1) During the hyperglycemic clamp the glucose stimulus presented to the
beta cell is controlled; thus, repeat studies of beta cell sensitivity
can be accurately interpreted and compared before and after induction of

metabolic acisosis.

Furthermore, since the glucose stimulus is

presented as a square wave one can examine the early and late phases
of insulin secretion independently.
(2) In both the hyperglycemic and euglycemic clamps, the plasma
glucose concentration is held constant.

Consequently, the amount of

glucose infused must equal the amount of glucose metabolized by all the
tissues of the body (minus urinary glucose losses) and thus allows
quantitation of the glucose metabolized.
(3) The euglycemic clamp offers major advantages over the insulin
tolerance test in assessing insulin sensitivity, since the basal glucose
concentration is maintained, thereby avoiding the complex neuro-endocrine
response to hypoglycemia.

The test thus provides a purer estimate of

sensitivity to insulin.
(4) Tissue insensitivity to insulin could reside in peripheral
tissues (muscle, adipose) or in the liver.

By performing the

euglycemic clamp in combination with [^T] glucose the contribution of
increased hepatic glucose production to the observed insulin resistance
can be determined.
(5) The hyperglycemic and euglycemic clamps provide independent
tests of the sensitivity of the body to endogenously-released and to
exogenously-administered insulin.
The results of the hyperglycemic and euglycemic clamps clearly
demonstrate that metabolic acidosis results in the impairment of glucose
tolerance and that the effect of acidosis is mediated via decreased sensitivity
to insulin.

During the hyperglycemic clamp, a decline in glucose

metabolism was observed despite a 26% increase in the plasma insulin
response.

Consequently, the M/I ratio (a measure of tissue sensitivity

to insulin) fell significantly in all five subjects by an average of
32% (p<0.02).

The presence of insulin resistance is also suggested

by the elevated fasting insulin levels in the face of normal glucose
concentrations.
Seven subjects also received a euglycemic clamp study to provide an
independent measure of tissue sensitivity to insulin.

Tissue sensitivity

to insulin declined in 6 of the 7 by an averaae of 1 2%.

When the

results of the euglycemic clamp are combined with those of the
hyperglycemic clamp a hiahly significant decline (p<0.01) in tissue
sensitivity to insulin following metabolic acidosis is observed.

These

results indicate that mild metabolic acidosis (mean decline in blood pH and
serum bicarbonate concentration = 0.04 and 4 mE q/L respectively) results
in decreased glucose tolerance which is mediated via tissue insensitivity
to insulin.

Beta cell sensitivity to olucose is not affected and insulin

secretion is augmented in an attempt to overcome this insulin resistance.
It is likely that more severe dearees of metabolic acidosis which are
maintained for longer periods of time will result in even areater insulin
resistance.

Attempts to administer ammonium chloride loads nreater than

0.15 grams/kg body wt/day in human subjects were poorlv tolerated and
the effect of more severe acidosis on olucose metabolism could not be
examined.
The studies with [^T]-qlucose suooest that the insulin resistance
resides in the periphery rather than with the liver.

Prior to the

administration of NH^Cl, basal hepatic glucose production averaaed 1.85
mg/kg/min.

Following NH^Cl basal glucose production was unchanged.(Table V).

Thus, unlike ranal gluconeoaenesis which is stimulated bv metabolic
acidosis (25), hepatic glucose production appears to be unaffected.
Although these results exclude augmented basal hepatic olucose production

as the cause of the observed insulin resistance, it is still
possible that incomplete suppression of glycogenolysis and/or
gluconeogenesis by insulin is responsible for the decline in glucose
tolerance.

The answer to this question awaits final completion of the

pT] glucose data.

Although basal plasma glucagon levels were mildly

elevated following NH4CI, it is unlikely that such a small increase
could have any significant effect in augmenting hepatic glucose production
on a sustained basis (26).

Furthermore, both hyperinsulinemia and

hyperglycemia resulted in normal glucagon suppression in the presence
of systemic acidosis.
It is well known that insulin lowers the systemic concentration
of certain amino acids, most notably valine, leucine, isoleucine,
methionine, tyrosine, and phenylalanine (27).

This effect of insulin

appears to be the result of net inhibition of amino acid output from
muscle (28).

To examine whether the insulin resistance observed with

glucose metabolism also extends to amino acid metabolism, we measured
the

fall in

circulating amino acids during the euglycemic clamp studies

in three subjects.

Following the administration of insulin a prompt

decline in plasma valine, leucine, isoleucine, methionine, tyrosine,
phenylalanine, and serine was observed in
after NH4Cl.*Thus,

all subjects both before and

it appears that the insulin resistance observed

following the induction of metabolic acidosis is specific for
carbohydrate metabolism.
* TABLE IV

SUMMARY:
The effect of metabolic acidosis on glucose metabolism was examined
in

12

healthy volunteers employing two types of glucose clamp experiments.

Each subject was studied before and after the ingestion of 0.1 gm of ammonium
chloride per kg body wt. per day for three days.

For all subjects, the fasting

insulin concentration rose significantly without change in the fasting glucose
concentration.
Hyperglycemic clamp:

The plasma glucose concentration is acutely raised

and maintained at 125 mg/dl above the fasting level for two hours by the
periodic adjustment of a variable glucose infusion.

Since the glucose

concentration is held constant, the glucose infusion rate is on index of glucose
metabolism (M).

Following ammonium chloride M declined from 9.09 to 7.43 mg/kg

body wt/min (p=0.10) despite a rise in plasma insulin response.

Consequently,

the M/I ratio, an index of tissue sensitivity to endogenous insulin, declined
in all subjects by 35% (p<0.005).
Euglycemic clamp:
approximately 100

The plasma insulin concentration is acutely raised

U/ml above basal levels and is maintained by a prime-

continuous insulin infusion.

The blood glucose concentration is held constant

by a variable glucose infusion.

M/I is again a measure of time sensitivity to

exogenous insulin and fell by 10% (p=0.09).

A normal decline in plasma amino

acids value, leucine, isoleucine, methionine, tyrosine, phenylalanine, and serine
was observed both before and after the induction of metabolic acidosis.
Both the hyperglycemic and euglycemic clamp techniques demonstrate tissue
insensitivity to insulin following NH4CI induced metabolic acidosis.

The

tissue resistance to insulin is specific for glucose metabolism and does not
extend to amino acid metabolism.
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Legend to Figures

Figure 1.

The time course of the mean plasma insulin concentration
during the hyperglycemic clamp in normal subjects pre ( ©
and post (O
represent the

Figure 2.

) ammonium chloride.

)

The height of the bars

EM.*=P <0.05; **=P <0.02.

The time course of the mean (-SEM) plasma glucagon concentration
during the hyperglycemic clamp in normal subjects pre and
post ammonium chloride.

Figure 3.

*=P< 0.005; **=P <0.05.

The time course of the mean (*SEM) plasma insulin concentration
during the euglycemic clamp in normal subjects pre arid post
ammonium chloride.

Figure 4.

*=P< 0.05;

**=P <0.02.

The time course of the mean (-SEM) plasma glucagon
concentration during the euglycemic clamp in normal subjects
pre and post ammonium chloride.

*=P <0.02; **=P <0,05.
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